Sign Up Now to Download a Free Research Report on GILD
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Gilead Sciences, Inc.
Gilead Sciences shares traded in the range of $55.75 to $58.06 Wednesday on volume of over 10.0 million shares traded. The company announced that the European Medicines Agency has accepted its marketing authorization application for its Hepatitis C treatment, Sofosbuvir.
Going forward ... (see research report)
Subscribe to News Feeds